Skip to main content
OpenTrials

Clinical trial condition

Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8

Explore clinical trials studying Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8. Study availability and eligibility vary by location and protocol.

13 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 trial results

Recruiting

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

NCT03801876

Conditions
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, +10 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
View all 96 locations
View Trial Details
Completed

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

NCT03707574

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Melanoma, +85 more
Locations
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States
  • Hawaii Cancer Care Inc - Waterfront Plaza Honolulu, Hawaii, United States
  • Island Urology Honolulu, Hawaii, United States
View all 144 locations
View Trial Details
Completed

Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma

NCT04097028

Conditions
Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, +13 more
Locations
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Stephenson Oklahoma Cancer Center at the University of Oklahoma Health Science Center Oklahoma City, Oklahoma, United States
View Trial Details
Completed

IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer

NCT03918499

Conditions
Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, +15 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Texas Oncology at Baylor Charles A Sammons Cancer Center Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

NCT05836584

Conditions
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, +7 more
Locations
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
  • Kaiser Permanente-Fresno Fresno, California, United States
  • Kaiser Permanente-Modesto Modesto, California, United States
View all 133 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

NCT04460937

Conditions
Adenocarcinoma Of Esophagus, Brain Diseases, Brain Neoplasms, +80 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions